Breaking News

Friday Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
On The Fly	Sell these stocks now, proven algorithm says » 11:09 07/01/22 07/01 11:09 07/01/22 11:09 RIVN Rivian Automotive $25.76 / +0.03 (+0.12%) , FTCH Farfetch $7.36 / +0.18 (+2.51%) , SEDG SolarEdge $276.44 / +3.57 (+1.31%) , CRON Cronos Group $2.82 / +0.01 (+0.36%) , SQ Block $63.57 / +2.08 (+3.38%) , WRBY Warby Parker $11.19 / -0.05 (-0.44%) , SNAP Snap $12.89 / -0.23 (-1.75%) , NEO NeoGenomics $8.40 / +0.25 (+3.07%) , MSTR MicroStrategy $165.00 / +1.67 (+1.02%) , LSPD Lightspeed $22.64 / +0.36 (+1.62%) , BILI Bilibili $26.11 / +0.52 (+2.03%) , GDS GDS Holdings $34.16 / +0.86 (+2.58%) , NUTX Nutex Health $3.31 / +0.09 (+2.80%) , RXRX Recursion Pharmaceuticals $8.65 / +0.52 (+6.40%) Each week, The Fly will… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options WRBY SQ SNAP SEDG RXRX RIVN NUTX NEO MSTR LSPD GDS FTCH CRON BILI WRBY Warby Parker $11.19 / -0.05 (-0.44%) 05/22/22 Fly Intel: Top five weekend stock stories 05/16/22 Warby Parker reports active customers increased 18.0% to 2.23M in Q1 03/17/22 Warby Parker drops 12% to $23.60 after FY22 revenue guidance misses estimates 03/11/22 Warby Parker announces new partnership with Eastman Chemical SQ Block $63.57 / +2.08 (+3.38%) 06/23/22 RumbleON adds Shin Lee to board of directors 06/21/22 Cathie Wood's ARK Investment bought 82K shares of Block today 06/08/22 Block's Afterpay, HBX partner to offer flexible spending for shoppers 06/06/22 Affirm, Block on watch as Apple previews "buy now, pay later" feature SNAP Snap $12.89 / -0.23 (-1.75%) 06/29/22 Snap announces Snapchat+ subscription service 06/21/22 Snap CEO sees 'ton of headroom' to grow considering size of audience 06/21/22 Snap CEO calls paid subscription test 'an exciting opportunity' 06/21/22 Snap CEO says not concerned by share price, focused on long-term SEDG SolarEdge $276.44 / +3.57 (+1.31%) 06/06/22 President Biden announces executive action on clean energy technologies 05/19/22 SolarEdge, Huawei sign global patent license agreement, end patent litigation 02/04/22 Biden extends tariffs on imported solar equipment another four years RXRX Recursion Pharmaceuticals $8.65 / +0.52 (+6.40%) 06/20/22 Recursion announces initiation of Phase 2/3 trial for NF2-Mutated Meningiomas 04/11/22 Recursion Pharmaceuticals granted FDA Fast Track designation for REC-4881 03/18/22 Recursion Pharmaceuticals enrolls first patient in Phase 2 SYCAMORE trial 03/03/22 Recursion provides updated guidance on clinical trial starts RIVN Rivian Automotive $25.76 / +0.03 (+0.12%) 06/26/22 Fly Intel: Top five weekend stock stories 06/06/22 Rivian says roadmap focused so cash can support 2025 launch of R2 platform 06/06/22 Rivian Automotive to host first annual shareholder meeting 05/31/22 Rivian Automotive director buys $1.17M in common stock NUTX Nutex Health $3.31 / +0.09 (+2.80%) 06/27/22 Nutex Health selected to join Russell 2000, Russell 3000 indexes 06/10/22 Nutex Health appoints Jon Bates as CFO 05/16/22 Nutex Health announces two new micro hospitals NEO NeoGenomics $8.40 / +0.25 (+3.07%) 06/03/22 NeoGenomics receives CAP certfication in Suzhou China laboratory 05/16/22 NeoGenomics appoints Lynn Terault as interim CEO 05/16/22 NeoGenomics Chief Strategy and Corporate Development Officer to step down 05/16/22 NeoGenomics appoints Lynn Tetrault interim CEO MSTR MicroStrategy $165.00 / +1.67 (+1.02%) 06/29/22 MicroStrategy acquired 480 bitcoins for $10M in cash in May and June 06/15/22 MicroStrategy up 8% to $170, off highs as CEO interview ends on CNBC 06/15/22 MicroStrategy CEO says strategy is to be 'levered, long bitcoin' 06/15/22 MicroStrategy CEO says excess cash will be used to buy more bitcoin LSPD Lightspeed $22.64 / +0.36 (+1.62%) 06/09/22 Lightspeed, Threedium enter partnership for 3D product visualization 06/02/22 Lightspeed launches new B2B platform 05/13/22 Lightspeed rises 26.8% 05/13/22 Lightspeed rises 18.1% GDS GDS Holdings $34.16 / +0.86 (+2.58%) 04/27/22 GDS Holdings, YTL partner on 168MW data center development FTCH Farfetch $7.36 / +0.18 (+2.51%) 05/27/22 Farfetch rises 22.8% 05/27/22 Farfetch rises 14.7% 05/26/22 Farfetch sees FY22 Digital GMV up 5%-10% and Brand Platform GMV up 10%-15% 04/05/22 Farfetch, Neiman Marcus Group announce global strategic partnership CRON Cronos Group $2.82 / +0.01 (+0.36%) 06/27/22 Cronos Group announces partnership with Geocann 06/21/22 Cronos Group, Ginkgo Bioworks announce achievement of THCV equity milestone 06/21/22 Ginkgo Bioworks and Cronos Group achieve THCV productivity milestone 03/21/22 Cronos Group founder Mike Gorenstein returns as CEO BILI Bilibili $26.11 / +0.52 (+2.03%) 05/05/22 Bilibili provides update on status under HFCAA 05/02/22 Bilibili provides update on voluntary conversion to dual-primary listing 03/03/22 Bilibili announces $500M share repurchase program, CEO to purchase $10M shares RIVN FTCH SEDG CRON SQ WRBY SNAP NEO MSTR LSPD BILI GDS NUTX RXRX RIVN Rivian Automotive $25.76 / +0.03 (+0.12%) 06/30/22 RBC Capital RBC confident in Rivian Automotive achieving Q2 delivery estimates 06/27/22 Mizuho Rivian Automotive price target lowered to $70 from $80 at Mizuho 06/15/22 Mizuho Mizuho likes three electric vehicle stocks into second half rebound 06/06/22 Deutsche Bank Tesla workforce reduction 'direct warning' to industry, says Deutsche Bank FTCH Farfetch $7.36 / +0.18 (+2.51%) 06/29/22 JPMorgan Farfetch price target lowered to $16 from $20 at JPMorgan 06/28/22 UBS UBS downgrades 'profitless-tech company' Farfetch to Neutral 06/28/22 UBS Farfetch downgraded to Neutral from Buy at UBS 06/06/22 Cowen Farfetch price target lowered to $11 from $30 at Cowen SEDG SolarEdge $276.44 / +3.57 (+1.31%) 06/29/22 Roth Capital Roth sees CBP requiring quartzite docs as 'major problem' for solar industry 06/29/22 Wells Fargo Generac initiated with an Overweight at Wells Fargo 06/02/22 Oppenheimer Oppenheimer upgrades SolarEdge to Outperform with $334 price target 06/02/22 Oppenheimer Oppenheimer upgrades Wolfspeed to Outperform with $105 price target CRON Cronos Group $2.82 / +0.01 (+0.36%) 05/11/22 CIBC CIBC upgrades Cronos to buy on 'multiple reasons for optimism' 05/11/22 Canaccord Cronos upgraded to Hold on operational improvements at Canaccord 05/11/22 CIBC Cronos Group upgraded to Outperformer from Neutral at CIBC 05/11/22 Canaccord Cronos Group upgraded to Hold from Sell at Canaccord SQ Block $63.57 / +2.08 (+3.38%) 06/30/22 Truist Block price target lowered to $105 from $145 at Truist 06/17/22 Mizuho Marqeta has negotiating leverage with Square, says Mizuho 06/15/22 Credit Suisse Block price target lowered to $170 from $180 at Credit Suisse 06/07/22 Mizuho PayPal sales could rise 20% if Apple enables Venmo tap, says Mizuho WRBY Warby Parker $11.19 / -0.05 (-0.44%) 06/27/22 Loop Capital Warby Parker price target lowered to $15 from $18 at Loop Capital 05/17/22 Goldman Sachs Warby Parker downgraded to Neutral from Buy at Goldman Sachs 05/17/22 Baird Warby Parker price target lowered to $30 from $40 at Baird 05/17/22 Citi Warby Parker price target lowered to $29 from $41 at Citi SNAP Snap $12.89 / -0.23 (-1.75%) 06/30/22 JMP Securities Snap price target lowered to $42 from $45 at JMP Securities 06/29/22 JPMorgan Snap price target lowered to $24 from $26 at JPMorgan 06/22/22 Guggenheim Snap price target lowered to $18 from $35 at Guggenheim 06/16/22 UBS Snap price target lowered to $17 from $45 at UBS NEO NeoGenomics $8.40 / +0.25 (+3.07%) 06/02/22 Piper Sandler NeoGenomics initiated with an Overweight at Piper Sandler 03/29/22 Cowen NeoGenomics price target lowered to $24 from $42 at Cowen 03/29/22 BTIG NeoGenomics price target lowered to $28 from $35 at BTIG 03/29/22 SVB Securities NeoGenomics price target lowered to $20 from $45 at SVB Leerink MSTR MicroStrategy $165.00 / +1.67 (+1.02%) 06/16/22 Jefferies Jefferies cuts MicroStrategy target, says does not face solvency risk 06/14/22 BTIG MicroStrategy margin call concerns 'blown out of proportion,' says BTIG 05/23/22 Jefferies MicroStrategy price target lowered to $215 from $225 at Jefferies 05/16/22 Jefferies MicroStrategy does not face liquidity, solvency risk, says Jefferies LSPD Lightspeed $22.64 / +0.36 (+1.62%) 06/03/22 Piper Sandler Lightspeed price target raised to $40 from $39 at Piper Sandler 05/20/22 TD Securities Lightspeed price target lowered to C$60 from C$80 at TD Securities 05/20/22 Raymond James Lightspeed price target raised to C$43 from C$40 at Raymond James 05/20/22 Truist Lightspeed price target lowered to $45 from $60 at Truist BILI Bilibili $26.11 / +0.52 (+2.03%) 06/13/22 JPMorgan Bilibili price target raised to $25 from $19 at JPMorgan 06/10/22 Citi Bilibili price target lowered to $45 from $46 at Citi 06/10/22 Barclays Bilibili price target raised to $26 from $24 at Barclays 06/10/22 ICBC Bilibili downgraded to Neutral from Outperform at ICBC GDS GDS Holdings $34.16 / +0.86 (+2.58%) 06/06/22 RBC Capital GDS Holdings price target lowered to $41 from $58 at RBC Capital 05/19/22 Truist GDS Holdings price target lowered to $75 from $85 at Truist 05/19/22 Cowen GDS Holdings price target lowered to $47 from $53 at Cowen 05/19/22 Raymond James GDS Holdings price target lowered to $55 from $68 at Raymond James NUTX Nutex Health $3.31 / +0.09 (+2.80%) RXRX Recursion Pharmaceuticals $8.65 / +0.52 (+6.40%) 04/18/22 BofA Recursion Pharmaceuticals downgraded to Neutral from Buy at BofA 03/04/22 SVB Securities Recursion Pharmaceuticals downgraded to Market Perform from Outperform at SVB Leerink 09/21/21 Berenberg Recursion Pharmaceuticals initiated with a Buy at Berenberg WRBY SQ SNAP SEDG RXRX RIVN NEO MSTR LSPD GDS FTCH CRON BILI WRBY Warby Parker $11.19 / -0.05 (-0.44%) 05/16/22 Warby Parker backs FY22 revenue view $650M-$660M, consensus $656.98M 05/16/22 Warby Parker reports Q1 adjusted EPS (30c), consensus 1c 03/17/22 Warby Parker sees 2022 revenue $650M-$660M, consensus $687.75M 03/17/22 Warby Parker reports Q4 adjusted EPS (8c), consensus (9c) SQ Block $63.57 / +2.08 (+3.38%) 05/05/22 Block reports Q1 adjusted EPS 18c, consensus 21c 05/05/22 Notable companies reporting after market close 02/24/22 Block reports Q4 adjusted EPS 27c, consensus 22c 02/24/22 Notable companies reporting after market close SNAP Snap $12.89 / -0.23 (-1.75%) 05/23/22 Snap sees Q2 revenue, adjusted EBITDA below low end of prior guidance 04/21/22 Snap sees Q2 revenue up 20%-25% y/y, consensus $1.26B 04/21/22 Snap reports Q1 EPS (2c), consensus 1c 04/21/22 Notable companies reporting after market close SEDG SolarEdge $276.44 / +3.57 (+1.31%) 05/02/22 SolarEdge sees Q2 revenue $710M-$740M, consensus $687.12M 05/02/22 SolarEdge reports Q1 adjusted EPS $1.20, consensus $1.27 02/15/22 SolarEdge sees Q1 revenue $615M-$645M, consensus $578.6M 02/15/22 SolarEdge reports Q4 adjusted EPS $1.10, consensus $1.31 RXRX Recursion Pharmaceuticals $8.65 / +0.52 (+6.40%) 03/23/22 Recursion Pharmaceuticals reports Q4 EPS (38c), consensus (31c) RIVN Rivian Automotive $25.76 / +0.03 (+0.12%) 05/11/22 Rivian Automotive reports Q1 adjusted EPS ($1.43), consensus ($1.44) 05/11/22 Notable companies reporting after market close 04/28/22 Amazon reports Q1 EPS ($7.56) with Rivian expense, consensus $8.36 03/10/22 Rivian sees FY22 adjusted EBITDA ($4.75B) NEO NeoGenomics $8.40 / +0.25 (+3.07%) 04/27/22 NeoGenomics reports Q1 adjusted EPS (20c), consensus (23c) 04/26/22 Notable companies reporting before tomorrow's open 03/28/22 NeoGenomics now sees Q1 revenue below $118M-$120M range, consensus $119.16M MSTR MicroStrategy $165.00 / +1.67 (+1.02%) 05/03/22 MicroStrategy reports Q1 adjusted EPS ($10.42), two estimates $1.41 02/01/22 MicroStrategy reports Q4 EPS ($8.43), consensus $1.49 LSPD Lightspeed $22.64 / +0.36 (+1.62%) 05/20/22 Lightspeed sees FY23 revenue of $740M-$760M 05/20/22 Lightspeed sees Q1 revenue of $165M-$170M 05/20/22 Lightspeed reports Q4 adjusted EPS (15c) vs. (10c) a year ago 02/02/22 Lightspeed sees FY22 revenue $540M-$544M, up from $520M-$535M GDS GDS Holdings $34.16 / +0.86 (+2.58%) 05/19/22 GDS Holdings backs FY22 revenue view of RMB 9.32B - RMB 9.68B 05/19/22 GDS Holdings reports Q1 EPS (50c), consensus (25c) 03/22/22 GDS Holdings sees 2022 revenue RMB 9.32B - RMB 9.68B 03/22/22 GDS Holdings reports Q4 EPS (30c), consensus (18c) FTCH Farfetch $7.36 / +0.18 (+2.51%) 05/26/22 Farfetch reports Q1 EPS (24c), consensus (28c) 02/24/22 Farfetch reports Q4 adjusted EPS (3c), consensus (3c) CRON Cronos Group $2.82 / +0.01 (+0.36%) 05/10/22 Cronos Group reports Q1 EPS (9c), consensus (8c) 03/01/22 Cronos Group reports 2021 EPS ($1.07), consensus (47c) 02/18/22 Cronos Group reports Q3 EPS 21c, consensus (10c) BILI Bilibili $26.11 / +0.52 (+2.03%) 06/09/22 Bilibili sees Q2 revenue RMB4.85B-RMB4.95B from RMB5.05B in Q1 06/09/22 Bilibili reports Q1 adjusted EPS (66c), consensus (62c) 06/08/22 Notable companies reporting before tomorrow's open 03/03/22 Bilibili sees Q1 revenue RMB 5.3B-RMB 5.5B 18 Mar 10 Nov 29 Sep 09 Aug WRBY SQ SNAP SEDG RIVN MSTR GDS CRON BILI WRBY Warby Parker $11.19 / -0.05 (-0.44%) 05/21/22 Robinhood among broken IPOs that could be buys, Barron's says SQ Block $63.57 / +2.08 (+3.38%) 06/23/22 Klarna's valuation set to slip, bringing fintech star down to earth, WSJ says 06/21/22 Paya working with advisor to explore sale, Bloomberg reports 06/01/22 'Buy now, pay later' companies impacted by late payments, losses, WSJ reports 05/19/22 Klarna looks to raise up to $1B at lower valuation, WSJ reports SNAP Snap $12.89 / -0.23 (-1.75%) 06/28/22 Meta, Snap could face penalties for addicting children in California, WSJ says 06/17/22 Snap tells The Verge testing paid subscription called Snapchat Plus 05/23/22 Snap to slow hiring through end of year, CNBC reports 04/26/22 Tech giants tricked into giving out personal user data, Bloomberg says SEDG SolarEdge $276.44 / +3.57 (+1.31%) 06/27/22 German ministry says EU states agree to 40% renewables target, Reuters reports 06/06/22 White House to waive some solar panel tariffs for 24 months, Reuters reports 03/28/22 Commerce Department to investigate Asian solar-panel makers, Bloomberg says 01/27/22 WTO panel authorizes China to impose tariffs on U.S. imports, WSJ says RIVN Rivian Automotive $25.76 / +0.03 (+0.12%) 06/30/22 General Motors Hummer production lags offerings from Ford and Rivian, WSJ says 06/26/22 Tesla. Ford and GM raise EV prices as costs and demand grow, WSJ reports 06/25/22 Lucid stock looks more vulnerable than Tesla, other peers, Barron's says 06/14/22 Tesla CEO says rivals Rivian, Lucid 'tracking toward bankruptcy,' Electrek says MSTR MicroStrategy $165.00 / +1.67 (+1.02%) 05/19/22 MicroStrategy CFO says company won't change bitcoin plans, WSJ reports 03/16/22 Democrats split on whether to regulate crypto, Politico reports 03/09/22 Biden to order government to come up with plan to regulate crypto, NYT reports GDS GDS Holdings $34.16 / +0.86 (+2.58%) 04/22/22 Bain-backed Chindata receives preliminary takeover interest, Bloomberg says CRON Cronos Group $2.82 / +0.01 (+0.36%) 04/11/22 NJ approves sale of retail marijuana from seven dispensaries, Bloomberg says 04/01/22 U.S. House backs federal marijuana legalization bill, Marijuana Moment reports 03/24/22 House to vote on marijuana legalization bill next week, Marijuana Moment says BILI Bilibili $26.11 / +0.52 (+2.03%) 03/16/22 Chinese stocks jump as Beijing vows to keep markets stable, Reuters reports WRBY SQ SNAP SEDG RIVN NEO MSTR LSPD GDS FTCH CRON BILI WRBY Warby Parker $11.19 / -0.05 (-0.44%) 06/24/22 Sell these stocks now, proven algorithm says 05/16/22 What You Missed On Wall Street On Monday 05/16/22 What You Missed On Wall Street This Morning SQ Block $63.57 / +2.08 (+3.38%) 06/25/22 Opening Day: Golden Sun rises in debut as Ivanhoe Electric delays IPO 06/03/22 Sell these stocks now, proven algorithm says 06/01/22 What You Missed On Wall Street On Wednesday SNAP Snap $12.89 / -0.23 (-1.75%) 06/29/22 #SocialStocks: Pinterest taps former Google executive as CEO 06/22/22 #SocialStocks: Twitter board unanimously backs deal with Elon Musk 06/17/22 What You Missed On Wall Street On Friday SEDG SolarEdge $276.44 / +3.57 (+1.31%) 06/29/22 Solar stocks slide as analyst says products detained under new law 06/06/22 What You Missed On Wall Street On Monday RIVN Rivian Automotive $25.76 / +0.03 (+0.12%) 07/01/22 Sell these stocks now, proven algorithm says 06/27/22 What You Missed This Week in EVs and Clean Energy 06/13/22 What You Missed This Week in EVs and Clean Energy 06/06/22 What You Missed This Week in EVs and Clean Energy NEO NeoGenomics $8.40 / +0.25 (+3.07%) 05/06/22 Proven algorithm says sell these stocks now 04/29/22 Proven algorithm says sell these stocks now 04/27/22 Fly Intel: Pre-market Movers MSTR MicroStrategy $165.00 / +1.67 (+1.02%) 07/01/22 Here's What You Missed in Crypto This Week 06/17/22 Here's What You Missed in Crypto This Week LSPD Lightspeed $22.64 / +0.36 (+1.62%) 05/27/22 Sell these stocks now, proven algorithm says 04/05/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations GDS GDS Holdings $34.16 / +0.86 (+2.58%) 05/20/22 Proven algorithm says sell these stocks now 05/19/22 What You Missed On Wall Street On Thursday FTCH Farfetch $7.36 / +0.18 (+2.51%) 06/28/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/27/22 What You Missed On Wall Street On Friday 05/27/22 What You Missed On Wall Street This Morning CRON Cronos Group $2.82 / +0.01 (+0.36%) 06/30/22 Here's What You Missed in Cannabis This Week 06/23/22 Here's What You Missed in Cannabis This Week 06/16/22 Here's What You Missed in Cannabis This Week BILI Bilibili $26.11 / +0.52 (+2.03%) 06/17/22 Sell these stocks now, proven algorithm says 06/12/22 Sell these stocks now, proven algorithm says 06/09/22 What You Missed On Wall Street On Thursday 08/04/22 Block - SQ WRBY SQ SNAP SEDG RIVN NEO MSTR LSPD GDS FTCH CRON BILI WRBY Warby Parker $11.19 / -0.05 (-0.44%) 06/03/22 Largest borrow rate increases among liquid names 04/26/22 Largest borrow rate increases among liquid names 03/21/22 Largest borrow rate increases among liquid names SQ Block $63.57 / +2.08 (+3.38%) 06/23/22 Unusually active option classes on open June 23rd 05/05/22 Square options imply 10.3% move in share price post-earnings 03/23/22 Square put volume heavy and directionally bearish 03/07/22 Square put volume heavy and directionally bearish SNAP Snap $12.89 / -0.23 (-1.75%) 06/03/22 Notable open interest changes for June 3rd 05/25/22 Unusually active option classes on open May 25th 05/25/22 Notable open interest changes for May 25th 05/25/22 Snap Inc. put buyer realizes 61% same-day gains SEDG SolarEdge $276.44 / +3.57 (+1.31%) 06/02/22 Early notable gainers among liquid option names on June 2nd 05/18/22 Early notable gainers among liquid option names on May 18th 05/13/22 Early notable gainers among liquid option names on May 13th 04/27/22 Early notable gainers among liquid option names on April 27th RIVN Rivian Automotive $25.76 / +0.03 (+0.12%) 06/21/22 Rivian call volume above normal and directionally bullish 05/24/22 Rivian put volume heavy and directionally bearish 05/18/22 Rivian call volume above normal and directionally bullish 05/12/22 Notable open interest changes for May 12th NEO NeoGenomics $8.40 / +0.25 (+3.07%) 05/04/22 Largest borrow rate increases among liquid names MSTR MicroStrategy $165.00 / +1.67 (+1.02%) 05/31/22 MicroStrategy put volume heavy and directionally bearish 05/13/22 Unusually active option classes on open May 13th 02/01/22 MicroStrategy options imply 8.3% move in share price post-earnings LSPD Lightspeed $22.64 / +0.36 (+1.62%) 06/01/22 Largest borrow rate increases among liquid names 04/07/22 Unusually active option classes on open April 7th GDS GDS Holdings $34.16 / +0.86 (+2.58%) 05/18/22 GDS Holdings (ADS) options imply 9.5% move in share price post-earnings 04/14/22 GDS Holdings (ADS) put volume heavy and directionally bearish 04/11/22 GDS Holdings (ADS) put volume heavy and directionally bearish 04/07/22 GDS Holdings (ADS) put volume heavy and directionally bearish FTCH Farfetch $7.36 / +0.18 (+2.51%) 05/26/22 Farfetch Limited options imply 15.2% move in share price post-earnings 05/20/22 Unusually active option classes on open May 20th 05/19/22 Farfetch Limited call volume above normal and directionally bullish 04/26/22 Farfetch Limited put volume heavy and directionally bearish CRON Cronos Group $2.82 / +0.01 (+0.36%) 03/25/22 Unusually active option classes on open March 25th BILI Bilibili $26.11 / +0.52 (+2.03%) 06/08/22 Unusually active option classes on open June 8th 06/07/22 Bilibili call volume above normal and directionally bullish 06/03/22 Bilibili put volume heavy and directionally bearish 04/04/22 Bilibili call volume above normal and directionally bullish
Recommendations	Merit Medical price target lowered to $70 from $75 at Piper Sandler » 04:45 07/01/22 07/01 04:45 07/01/22 04:45 MMSI Merit Medical $54.14 / -0.02 (-0.04%) Piper Sandler analyst… Piper Sandler analyst Jason Bednar lowered the firm's price target on Merit Medical Systems to $70 from $75 and keeps an Overweight rating on the shares after hosting meetings with management. The analyst says management had "unwavering confidence" in hitting the fiscal 2023 18%-plus operating margin target embedded in its "Foundations For Growth" initiative. This "speaks volumes" in light of Q1 margin pressures and inflation uncertainties, and puts Merit Medical in a "select group" that should post consistent margin expansion over at least the next three years, Bednar tells investors in a research note. He's a buyer of the stock into next month's Q2 results. ShowHide Related Items >><< Company News Street Research Earnings Periodicals MMSI Merit Medical $54.14 / -0.02 (-0.04%) 04/21/22 Merit Medical COO Ronald Frost to retire, Neil Peterson to succeed 04/18/22 Merit Medical launches ReSolve Thoracostomy Tray 04/11/22 Merit Medical receives FDA clearance for SCOUT Bx Delivery System 04/08/22 PE firms showing interest in deal for Merit Medical, Reuters reports MMSI Merit Medical $54.14 / -0.02 (-0.04%) 04/28/22 Barrington Merit Medical price target lowered to $78 from $82 at Barrington 03/10/22 Piper Sandler Piper not ruling out Merit Medical takeout despite 'odd' timing 02/25/22 Barrington Merit Medical price target raised to $82 from $78 at Barrington 02/25/22 Piper Sandler Merit Medical price target lowered to $75 from $79 at Piper Sandler MMSI Merit Medical $54.14 / -0.02 (-0.04%) 04/27/22 Merit Medical reports Q1 EPS53c, consensus 46c MMSI Merit Medical $54.14 / -0.02 (-0.04%) 04/08/22 PE firms expressed interest in acquiring Merit Medical, Reuters says 04/08/22 PE firms expressed interest in acquiring Merit Medical, Reuters says 03/09/22 Merit Medical exploring possible sale to PE firm, Reuters reports 03/09/22 Merit Medical exploring options including possible sale, Reuters reports

Wednesday
Conference/Events	Merit Medical management to meet virtually with Piper Sandler » 04:55 06/29/22 06/29 04:55 06/29/22 04:55 MMSI Merit Medical $53.76 / -1.15 (-2.09%) Virtual Meetings to be… Virtual Meetings to be held on June 28-29 hosted by Piper Sandler. ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events MMSI Merit Medical $53.76 / -1.15 (-2.09%) 04/21/22 Merit Medical COO Ronald Frost to retire, Neil Peterson to succeed 04/18/22 Merit Medical launches ReSolve Thoracostomy Tray 04/11/22 Merit Medical receives FDA clearance for SCOUT Bx Delivery System 04/08/22 PE firms showing interest in deal for Merit Medical, Reuters reports MMSI Merit Medical $53.76 / -1.15 (-2.09%) 04/28/22 Barrington Merit Medical price target lowered to $78 from $82 at Barrington 03/10/22 Piper Sandler Piper not ruling out Merit Medical takeout despite 'odd' timing 02/25/22 Barrington Merit Medical price target raised to $82 from $78 at Barrington 02/25/22 Piper Sandler Merit Medical price target lowered to $75 from $79 at Piper Sandler MMSI Merit Medical $53.76 / -1.15 (-2.09%) 04/27/22 Merit Medical reports Q1 EPS53c, consensus 46c MMSI Merit Medical $53.76 / -1.15 (-2.09%) 04/08/22 PE firms expressed interest in acquiring Merit Medical, Reuters says 04/08/22 PE firms expressed interest in acquiring Merit Medical, Reuters says 03/09/22 Merit Medical exploring possible sale to PE firm, Reuters reports 03/09/22 Merit Medical exploring options including possible sale, Reuters reports 06/29/22 Merit Medical

Over a week ago
Hot Stocks	Brainsway announces insurance coverage by Israeli Ministry of Health » 08:16 06/28/22 06/28 08:16 06/28/22 08:16 BWAY Brainsway $5.21 / +0.12 (+2.36%) BrainsWay announced that,… BrainsWay announced that, for the first time, the Israeli Ministry of Health has approved coverage applicable to its Deep TM system for the treatment of depression. The inclusion of the treatment within Israel's health basket of essential medical services means that the country's health funds must now make the treatment available to qualifying patients free of charge. Qualifying patients include adults over the age of 21 with depression who have either not responded to two prior antidepressants, or who are intolerant to other treatment alternatives. Coverage may be provided for up to 40 treatment sessions, which are to be administered in hospitals. ShowHide Related Items >><< Company News Street Research Earnings BWAY Brainsway $5.21 / +0.12 (+2.36%) 06/21/22 Brainsway announces positive OCD coverage policy from BCBS for Deep TMS 05/11/22 Neuronetics files lawsuit against Brainsway for unfair competition 05/09/22 Brainsway appoints Eric Hirt as VP of U.S. sales 05/02/22 Brainsway launches #DontMissAnotherMoment social media campaign BWAY Brainsway $5.21 / +0.12 (+2.36%) 03/02/22 Loop Capital Loop Capital starts Brainsway at Buy with $15 price target 03/02/22 Loop Capital Brainsway initiated with a Buy at Loop Capital 02/10/22 Northland Brainsway transferred with an Outperform at Northland 11/29/21 H.C. Wainwright Brainsway price target raised to $15 from $14 at H.C. Wainwright BWAY Brainsway $5.21 / +0.12 (+2.36%) 05/11/22 Brainsway reports Q1 EPS (6c) vs (5c) last year 03/09/22 Brainsway reports Q4 EPS (4c), one est. (7c)
Conference/Events	Merit Medical management to meet virtually with Piper Sandler » 04:55 06/28/22 06/28 04:55 06/28/22 04:55 MMSI Merit Medical $54.88 / +2 (+3.78%) Virtual Meetings to be… Virtual Meetings to be held on June 28-29 hosted by Piper Sandler. ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events MMSI Merit Medical $54.88 / +2 (+3.78%) 04/21/22 Merit Medical COO Ronald Frost to retire, Neil Peterson to succeed 04/18/22 Merit Medical launches ReSolve Thoracostomy Tray 04/11/22 Merit Medical receives FDA clearance for SCOUT Bx Delivery System 04/08/22 PE firms showing interest in deal for Merit Medical, Reuters reports MMSI Merit Medical $54.88 / +2 (+3.78%) 04/28/22 Barrington Merit Medical price target lowered to $78 from $82 at Barrington 03/10/22 Piper Sandler Piper not ruling out Merit Medical takeout despite 'odd' timing 02/25/22 Barrington Merit Medical price target raised to $82 from $78 at Barrington 02/25/22 Piper Sandler Merit Medical price target lowered to $75 from $79 at Piper Sandler MMSI Merit Medical $54.88 / +2 (+3.78%) 04/27/22 Merit Medical reports Q1 EPS53c, consensus 46c MMSI Merit Medical $54.88 / +2 (+3.78%) 04/08/22 PE firms expressed interest in acquiring Merit Medical, Reuters says 04/08/22 PE firms expressed interest in acquiring Merit Medical, Reuters says 03/09/22 Merit Medical exploring possible sale to PE firm, Reuters reports 03/09/22 Merit Medical exploring options including possible sale, Reuters reports 06/28/22 Merit Medical 06/29/22 Merit Medical
Conference/Events	LeMaitre management to meet with Barrington » 04:55 06/28/22 06/28 04:55 06/28/22 04:55 LMAT LeMaitre $45.37 / +0.32 (+0.71%) Meeting to be held on… Meeting to be held on June 28 hosted by Barrington. ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events LMAT LeMaitre $45.37 / +0.32 (+0.71%) 02/24/22 LeMaitre announces $20M share repurchase authorization LMAT LeMaitre $45.37 / +0.32 (+0.71%) 04/29/22 Barrington LeMaitre price target lowered to $50 from $54 at Barrington 02/25/22 Barrington LeMaitre price target lowered to $54 from $62 at Barrington 09/16/21 Fly Intel: Top five analyst initiations 09/16/21 Jefferies Jefferies starts LeMaitre at Buy on ArteGraft upside potential LMAT LeMaitre $45.37 / +0.32 (+0.71%) 04/28/22 LeMaitre sees FY22 ex-items EPS $1.21-$1.31, consensus $1.33 04/28/22 LeMaitre sees Q2 ex-items EPS 29c-35c, consensus 39c 04/28/22 LeMaitre reports Q1 EPS 27c, consensus 28c 02/24/22 LeMaitre reports Q4 EPS 28c, consensus 31c 14 Jul 06/28/22 LeMaitre
On The Fly	Sell these stocks now, proven algorithm says » 13:51 06/24/22 06/24 13:51 06/24/22 13:51 WRBY Warby Parker $14.11 / +0.64 (+4.75%) , DNA Ginkgo Bioworks $2.85 / -0.085 (-2.90%) , RXRX Recursion Pharmaceuticals $8.49 / -0.785 (-8.46%) , MSTR MicroStrategy $200.01 / +11.95 (+6.35%) , SWTX SpringsWorks Therapeutics $25.22 / -0.38 (-1.48%) Each week, The Fly will… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options WRBY SWTX RXRX MSTR DNA WRBY Warby Parker $14.11 / +0.64 (+4.75%) 05/22/22 Fly Intel: Top five weekend stock stories 05/16/22 Warby Parker reports active customers increased 18.0% to 2.23M in Q1 03/17/22 Warby Parker drops 12% to $23.60 after FY22 revenue guidance misses estimates 03/11/22 Warby Parker announces new partnership with Eastman Chemical SWTX SpringsWorks Therapeutics $25.22 / -0.38 (-1.48%) 05/26/22 SpringsWorks Therapeutics presents Nirogacestat Clinical Data at 2022 ASCO 05/24/22 SpringsWorks Therapeutics: Nirogacestat achieved endpoints in Phase 3 DeFi trial 04/19/22 SpringsWorks announces agreeement with Regeneron for nirogacestat RXRX Recursion Pharmaceuticals $8.49 / -0.785 (-8.46%) 06/20/22 Recursion announces initiation of Phase 2/3 trial for NF2-Mutated Meningiomas 04/11/22 Recursion Pharmaceuticals granted FDA Fast Track designation for REC-4881 03/18/22 Recursion Pharmaceuticals enrolls first patient in Phase 2 SYCAMORE trial 03/03/22 Recursion provides updated guidance on clinical trial starts MSTR MicroStrategy $200.01 / +11.95 (+6.35%) 06/15/22 MicroStrategy up 8% to $170, off highs as CEO interview ends on CNBC 06/15/22 MicroStrategy CEO says strategy is to be 'levered, long bitcoin' 06/15/22 MicroStrategy CEO says excess cash will be used to buy more bitcoin 06/15/22 MicroStrategy CEO says 98% of world doesn't understand digital scarcity concept DNA Ginkgo Bioworks $2.85 / -0.085 (-2.90%) 06/21/22 Cronos Group, Ginkgo Bioworks announce achievement of THCV equity milestone 06/21/22 Ginkgo Bioworks and Cronos Group achieve THCV productivity milestone 06/07/22 Ginkgo Bioworks, Novo Nordisk to partner on expression systems 06/06/22 Ginkgo Bioworks acquires certain assets from Bitome WRBY DNA RXRX MSTR SWTX WRBY Warby Parker $14.11 / +0.64 (+4.75%) 05/17/22 Goldman Sachs Warby Parker downgraded to Neutral from Buy at Goldman Sachs 05/17/22 Baird Warby Parker price target lowered to $30 from $40 at Baird 05/17/22 Citi Warby Parker price target lowered to $29 from $41 at Citi 03/30/22 Stifel Warby Parker initiated with a Hold at Stifel DNA Ginkgo Bioworks $2.85 / -0.085 (-2.90%) 06/16/22 Jefferies Ginkgo Bioworks price target lowered to $4.35 from $11.50 at Jefferies 05/18/22 BofA BofA downgrades Ginkgo Bioworks to Underperform, halves target to $3 05/18/22 BofA Ginkgo Bioworks downgraded to Underperform from Neutral at BofA 03/31/22 BTIG Ginkgo Bioworks price target lowered to $6 from $12 at BTIG RXRX Recursion Pharmaceuticals $8.49 / -0.785 (-8.46%) 04/18/22 BofA Recursion Pharmaceuticals downgraded to Neutral from Buy at BofA 03/04/22 SVB Securities Recursion Pharmaceuticals downgraded to Market Perform from Outperform at SVB Leerink 09/21/21 Berenberg Recursion Pharmaceuticals initiated with a Buy at Berenberg MSTR MicroStrategy $200.01 / +11.95 (+6.35%) 06/16/22 Jefferies Jefferies cuts MicroStrategy target, says does not face solvency risk 06/14/22 BTIG MicroStrategy margin call concerns 'blown out of proportion,' says BTIG 05/23/22 Jefferies MicroStrategy price target lowered to $215 from $225 at Jefferies 05/16/22 Jefferies MicroStrategy does not face liquidity, solvency risk, says Jefferies SWTX SpringsWorks Therapeutics $25.22 / -0.38 (-1.48%) 06/06/22 H.C. Wainwright SpringsWorks price target lowered to $95 from $142 at H.C. Wainwright 06/06/22 H.C. Wainwright Turning Point Therapeutics downgraded to Neutral from Buy at H.C. Wainwright 05/27/22 Wedbush SpringsWorks Therapeutics price target lowered to $50 from $110 at Wedbush 05/24/22 Goldman Sachs SpringsWorks Therapeutics price target raised to $82 from $76 at Goldman Sachs WRBY SWTX RXRX MSTR DNA WRBY Warby Parker $14.11 / +0.64 (+4.75%) 05/16/22 Warby Parker backs FY22 revenue view $650M-$660M, consensus $656.98M 05/16/22 Warby Parker reports Q1 adjusted EPS (30c), consensus 1c 03/17/22 Warby Parker sees 2022 revenue $650M-$660M, consensus $687.75M 03/17/22 Warby Parker reports Q4 adjusted EPS (8c), consensus (9c) SWTX SpringsWorks Therapeutics $25.22 / -0.38 (-1.48%) 05/05/22 SpringsWorks Therapeutics reports Q1 EPS ($1.26), consensus ($1.02) 02/24/22 SpringsWorks Therapeutics reports Q4 EPS ($1.15), consensus (88c) RXRX Recursion Pharmaceuticals $8.49 / -0.785 (-8.46%) 03/23/22 Recursion Pharmaceuticals reports Q4 EPS (38c), consensus (31c) MSTR MicroStrategy $200.01 / +11.95 (+6.35%) 05/03/22 MicroStrategy reports Q1 adjusted EPS ($10.42), two estimates $1.41 02/01/22 MicroStrategy reports Q4 EPS ($8.43), consensus $1.49 DNA Ginkgo Bioworks $2.85 / -0.085 (-2.90%) 05/16/22 Ginkgo Bioworks sees FY22 revenue view to $375M-$390M from $325M-$340M 05/16/22 Ginkgo Bioworks reports Q1 revenue $168M, consensus $105.68M 03/28/22 Ginkgo Bioworks sees FY22 revenue $325M-$340M, consensus $305.75M 03/28/22 Ginkgo Bioworks reports Q4 EPS ($1.10), consensus (4c) 29 Sep WRBY MSTR WRBY Warby Parker $14.11 / +0.64 (+4.75%) 05/21/22 Robinhood among broken IPOs that could be buys, Barron's says MSTR MicroStrategy $200.01 / +11.95 (+6.35%) 05/19/22 MicroStrategy CFO says company won't change bitcoin plans, WSJ reports 03/16/22 Democrats split on whether to regulate crypto, Politico reports 03/09/22 Biden to order government to come up with plan to regulate crypto, NYT reports WRBY SWTX MSTR DNA WRBY Warby Parker $14.11 / +0.64 (+4.75%) 05/16/22 What You Missed On Wall Street On Monday 05/16/22 What You Missed On Wall Street This Morning 05/16/22 Fly Intel: Pre-market Movers 03/17/22 What You Missed On Wall Street On Thursday SWTX SpringsWorks Therapeutics $25.22 / -0.38 (-1.48%) 06/06/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/26/22 Fly Intel: After-Hours Movers 05/24/22 What You Missed On Wall Street On Tuesday 05/24/22 What You Missed On Wall Street This Morning MSTR MicroStrategy $200.01 / +11.95 (+6.35%) 06/17/22 Here's What You Missed in Crypto This Week 06/13/22 Fly Intel: Pre-market Movers 06/03/22 Sell these stocks now, proven algorithm says 05/27/22 Sell these stocks now, proven algorithm says DNA Ginkgo Bioworks $2.85 / -0.085 (-2.90%) 06/23/22 Here's What You Missed in Cannabis This Week 06/16/22 What You Missed On Wall Street On Thursday 06/16/22 What You Missed On Wall Street This Morning 05/18/22 What You Missed On Wall Street On Wednesday WRBY MSTR DNA WRBY Warby Parker $14.11 / +0.64 (+4.75%) 06/03/22 Largest borrow rate increases among liquid names 04/26/22 Largest borrow rate increases among liquid names 03/21/22 Largest borrow rate increases among liquid names MSTR MicroStrategy $200.01 / +11.95 (+6.35%) 05/31/22 MicroStrategy put volume heavy and directionally bearish 05/13/22 Unusually active option classes on open May 13th 02/01/22 MicroStrategy options imply 8.3% move in share price post-earnings DNA Ginkgo Bioworks $2.85 / -0.085 (-2.90%) 05/16/22 Ginkgo Bioworks options imply 17.2% move in share price post-earnings 03/28/22 Ginkgo Bioworks options imply 13.9% move in share price post-earnings 03/11/22 Largest borrow rate increases among liquid names 03/10/22 Largest borrow rate increases among liquid names
Recommendations	DexCom price target lowered to $105 from $135 at BTIG » 07:22 06/24/22 06/24 07:22 06/24/22 07:22 DXCM DexCom $75.21 / +3.57 (+4.98%) BTIG analyst Marie… BTIG analyst Marie Thibault lowered the firm's price target on DexCom to $105 from post-split $135 but keeps a Buy rating on the shares as part of a broader research note on medical technology and digital health names. The pain across the sector has been indiscriminate, and many companies that still offer healthy fundamentals, strong operating track records, and important product pipelines are losing a large portion of their market value, the analyst tells investors in a research note. Thibault adds that she prefers stocks with large cash balances, a line of sight to cash flow-breakeven, consistent quarterly outperformance, and multiples that compare well against pre-COVID levels. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options DXCM DexCom $75.21 / +3.57 (+4.98%) 05/31/22 Insulet down 11% after DexCom says 'not in active discussions' about merger 05/31/22 DexCom says 'not in active discussions regarding a merger transaction' 05/31/22 DexCom says 'not in active discussions regarding a merger transaction' 04/01/22 DexCom to launch Dexcom One Continuous Glucose Monitoring System in UK DXCM DexCom $75.21 / +3.57 (+4.98%) 06/01/22 Lake Street Abbott approval for Libre 3 'a huge positive' for Tandem, says Lake Street 05/31/22 Piper Sandler Abbott approval bodes well for DexCom, Tandem, says Piper Sandler 05/31/22 Stifel DexCom M&A response should put an end to recent dislocation, says Stifel 05/31/22 BTIG DexCom shares may be volatile after 'squashing' M&A report, says BTIG DXCM DexCom $75.21 / +3.57 (+4.98%) 04/28/22 DexCom reports Q1 EPS 93c, consensus 52c 02/10/22 DexCom sees FY22 revenue $2.82B-$2.94B, consensus $2.96B 02/10/22 DexCom reports Q4 EPS 68c, consensus 85c 02/10/22 Notable companies reporting after market close DXCM DexCom $75.21 / +3.57 (+4.98%) 05/23/22 Dexcom in talks to acquire diabetes-device company Insulet, Bloomberg says 05/23/22 DexCom in talks to acquire Insulet, Bloomberg reports DXCM DexCom $75.21 / +3.57 (+4.98%) 05/31/22 What You Missed On Wall Street On Tuesday 05/31/22 What You Missed On Wall Street This Morning 05/24/22 What You Missed On Wall Street On Tuesday 05/24/22 What You Missed On Wall Street This Morning DXCM DexCom $75.21 / +3.57 (+4.98%) 06/15/22 Largest borrow rate increases among liquid names 05/31/22 Early notable gainers among liquid option names on May 31st 04/01/22 Early notable gainers among liquid option names on April 1st 03/25/22 Early notable gainers among liquid option names on March 25th
Conference/Events	LeMaitre management to meet with Barrington » 07:22 06/23/22 06/23 07:22 06/23/22 07:22 LMAT LeMaitre $43.27 / +0.36 (+0.84%) Meeting to be held on… Meeting to be held on June 28 hosted by Barrington. ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events LMAT LeMaitre $43.27 / +0.36 (+0.84%) 02/24/22 LeMaitre announces $20M share repurchase authorization LMAT LeMaitre $43.27 / +0.36 (+0.84%) 04/29/22 Barrington LeMaitre price target lowered to $50 from $54 at Barrington 02/25/22 Barrington LeMaitre price target lowered to $54 from $62 at Barrington 09/16/21 Fly Intel: Top five analyst initiations 09/16/21 Jefferies Jefferies starts LeMaitre at Buy on ArteGraft upside potential LMAT LeMaitre $43.27 / +0.36 (+0.84%) 04/28/22 LeMaitre sees FY22 ex-items EPS $1.21-$1.31, consensus $1.33 04/28/22 LeMaitre sees Q2 ex-items EPS 29c-35c, consensus 39c 04/28/22 LeMaitre reports Q1 EPS 27c, consensus 28c 02/24/22 LeMaitre reports Q4 EPS 28c, consensus 31c 14 Jul 06/28/22 LeMaitre
Conference/Events	Merit Medical management to meet virtually with Piper Sandler » 16:43 06/21/22 06/21 16:43 06/21/22 16:43 MMSI Merit Medical $52.13 / +0.17 (+0.33%) Virtual Meetings to be… Virtual Meetings to be held on June 28-29 hosted by Piper Sandler. ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events MMSI Merit Medical $52.13 / +0.17 (+0.33%) 04/21/22 Merit Medical COO Ronald Frost to retire, Neil Peterson to succeed 04/18/22 Merit Medical launches ReSolve Thoracostomy Tray 04/11/22 Merit Medical receives FDA clearance for SCOUT Bx Delivery System 04/08/22 PE firms showing interest in deal for Merit Medical, Reuters reports MMSI Merit Medical $52.13 / +0.17 (+0.33%) 04/28/22 Barrington Merit Medical price target lowered to $78 from $82 at Barrington 03/10/22 Piper Sandler Piper not ruling out Merit Medical takeout despite 'odd' timing 02/25/22 Barrington Merit Medical price target raised to $82 from $78 at Barrington 02/25/22 Piper Sandler Merit Medical price target lowered to $75 from $79 at Piper Sandler MMSI Merit Medical $52.13 / +0.17 (+0.33%) 04/27/22 Merit Medical reports Q1 EPS53c, consensus 46c MMSI Merit Medical $52.13 / +0.17 (+0.33%) 04/08/22 PE firms expressed interest in acquiring Merit Medical, Reuters says 04/08/22 PE firms expressed interest in acquiring Merit Medical, Reuters says 03/09/22 Merit Medical exploring possible sale to PE firm, Reuters reports 03/09/22 Merit Medical exploring options including possible sale, Reuters reports 06/28/22 Merit Medical 06/29/22 Merit Medical

Get Full Fly Access

Breaking market intelligence sent straight to you: Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.

Up-to-date information on important industry events: Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.

News focused on the companies in your portfolio: Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.

14 Day Free Trial